Haemonetics Corporation (HAE) vs TransMedics Group, Inc. (TMDX)
Haemonetics Corporation and TransMedics Group, Inc. are both Medical Devices companies. Haemonetics Corporation is the larger, with a market value of $4.8B against $2.9B — 1.7× the size. TransMedics Group, Inc. trades at the lower P/E: 19.3× against 51.4×. TransMedics Group, Inc. grew revenue faster over the last twelve months: 25.8% against 0.44%. TransMedics Group, Inc. has the higher net margin (22.7% vs 7.12%) and the higher return on invested capital (5.62% vs 5.62%). Across the 21 metrics below, TransMedics Group, Inc. leads on 12 and Haemonetics Corporation on 9.
Valuation
Profitability
| Metric | HAE | TMDX | Medical Devices median |
|---|---|---|---|
| Gross margin | 59.03% | 58.69% | 56.01% |
| Operating margin | 11.86% | 12.21% | (15.03%) |
| Net margin | 7.12% | 22.69% | (20.40%) |
| Free cash flow margin | 21.64% | 11.82% | (7.24%) |
| Return on equity | 11.20% | 36.28% | (15.32%) |
| Return on assets | 3.99% | 12.88% | (19.72%) |
| Return on invested capital | 5.62% | 5.62% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack